T cell receptor–peptide–major histocompatibility complex complex and costimulatory molecules at the immune synapse (TCR–pMHC complex (with costimulatory molecules))

The TCR–peptide–major histocompatibility complex (TCR–pMHC) complex is the central recognition unit at the immune synapse, where a T cell interacts with an antigen-presenting cell (APC). The TCR on the T cell surface recognizes a specific antigenic peptide presented by a major histocompatibility complex (MHC) molecule on APCs, forming the TCR–pMHC complex. Recognition of this complex is essential for initiating adaptive immune responses and for the specificity of T cell immunity. In addition to the TCR–pMHC interaction, costimulatory molecules (such as CD28, CTLA-4, PD-1, and their ligands) are also present at the immune synapse; they modulate the outcome of TCR signaling by providing additional activating or inhibitory signals required for full T cell activation, tolerance, or exhaustion. The geometric and functional organization of the immune synapse, including these components, regulates T cell fate and is a major focus of immunotherapeutic strategies in cancer, infection, and autoimmunity.

Other names

TCR–peptide–MHC complexT cell receptor–MHC–peptide compleximmunological synapse (when referring to all associated molecules)TCR–pMHC–costimulation

Blockade of costimulatory signals (e.g., CTLA-4, PD-1 inhibitors release inhibition on T cell activation); Direct modulation of TCR signaling (rare, research stage); Targeted recognition of tumor or viral antigens presented by pMHC; Augmentation or inhibition of T cell responses via co-receptor modulation